Subgroups according to BASDAI/ASDAS category (baseline)
Por um escritor misterioso
Descrição
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications
Absolute changes in Bath Ankylosing Spondylitis Disease Activity Index
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis
IJMS, Free Full-Text
Change from baseline in BASFI, BASDAI, BASMI linear and ASDAS, and
Association between baseline fibromyalgianess severity groupings and
Frontiers Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees
Standardized ASDAS vs standardized SASDAS for (A) baseline pooled data
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials
